Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Stelzer Laurie
Relationship:   Chief Financial Officer
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   218,479    

Indirect Shares

   10,000      
Direct Value   $10,885,890    

Indirect Value

   $420,100      
Total Shares   228,479      
Total Value   $11,305,990      


Halozyme Therapeutics Inc $4,880,176 Mirati Therapeutics, Inc. $6,005,714 Halozyme Therapeutics Inc $4,880,176 Mirati Therapeutics, Inc. $6,005,714
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 53.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Halozyme Therapeutics Inc HALO SVP, Chief Financial O... 2020-02-22 116,167 2020-02-22 10,000    Premium*  
            Arena Pharmaceuticals Inc ARNA EVP & Chief Financial ... 2022-03-11 0 2021-03-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX Chief Financial Officer 2023-08-09 102,312 2022-06-01 0    Premium*  
* Premium Members only  

Records found :    37         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc Chief Financial Officer   •       –      –    2015-08-20 4 B $17.24 $172,384 I/I 10,000 10,000 1.99 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2016-06-15 4 OE $0.00 $0 D/D 6,875 16,875 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2017-02-03 4 OE $0.00 $0 D/D 23,120 29,995 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2017-02-03 4 D $12.26 $111,382 D/D (9,085) 20,910 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2017-06-15 4 OE $0.00 $0 D/D 6,875 27,785 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2017-06-15 4 D $13.05 $33,708 D/D (2,583) 25,202 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-02-03 4 OE $0.00 $0 D/D 23,120 48,322 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-02-03 4 D $18.37 $151,828 D/D (8,265) 40,057 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-02-22 4 D $19.28 $75,944 D/D (3,939) 47,510 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-02-22 4 OE $0.00 $0 D/D 11,392 51,449 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-06-15 4 OE $0.00 $0 D/D 6,875 54,385 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2018-06-15 4 D $19.02 $61,891 D/D (3,254) 51,131 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-03 4 OE $0.00 $0 D/D 23,119 74,250 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-03 4 D $16.12 $134,070 D/D (8,317) 65,933 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-14 4 D $16.54 $44,658 D/D (2,700) 71,042 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-14 4 OE $0.00 $0 D/D 7,809 73,742 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-22 4 OE $0.00 $0 D/D 11,392 82,434 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-02-22 4 D $16.81 $66,215 D/D (3,939) 78,495 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-06-15 4 D $15.73 $53,608 D/D (3,408) 81,962 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2019-06-15 4 OE $0.00 $0 D/D 6,875 85,370 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2020-02-03 4 OE $0.00 $0 D/D 23,119 105,081 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2020-02-03 4 D $19.21 $158,963 D/D (8,275) 96,806 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2020-02-12 4 OE $0.00 $0 D/D 11,262 108,068 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2020-02-12 4 D $20.00 $77,880 D/D (3,894) 104,174 0 -
HALO Halozyme Therapeutics Inc SVP, Chief Financial Officer   •       –      –    2020-02-14 4 OE $0.00 $0 D/D 7,809 111,983 0 -
  37  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us